Acción NSPX INSPYR THERAPEUTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Inspyr Therapeutics, Inc. Other OTC

Acciones

NSPX

US45782A4031

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Inspyr Therapeutics : Material Event - Form 8-K/A
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción RBSH
  4. Acción NSPX
  5. Noticias Inspyr Therapeutics, Inc.
  6. Otros idiomas
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA